Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,767 | 5,349 | 11,761 | 9,688 | 7,102 |
| Marketable Securities | 4,134 | 8,081 | 0 | 0 | 1,567 |
| Receivables | 3,656 | 3,716 | 1,065 | 1,885 | 0 |
| Inventories | 0 | N/A | 0 | 0 | 354 |
| Other current assets | 14,686 | 10,173 | 5,708 | 4,177 | 4,920 |
| TOTAL | $30,243 | $27,681 | $18,534 | $15,750 | $13,943 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 387 | 62 | 3 |
| TOTAL | $N/A | $N/A | $387 | $62 | $3 |
| Total Assets | $30,243 | $27,681 | $18,922 | $15,812 | $13,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 60 | 1,625 | 827 | 1,408 |
| Other current liabilities | 88 | 71 | 105 | 166 | 3 |
| TOTAL | $88 | $131 | $1,730 | $993 | $1,411 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $88 | $131 | $1,730 | $993 | $1,411 |
| Shareholders' Equity | |||||
| Common Shares | 14 | 14 | 14 | 14 | 0 |
| Retained earnings | 23,577 | 20,972 | 17,174 | 14,801 | 12,547 |
| TOTAL | $30,155 | $27,550 | $17,192 | $14,819 | $12,547 |
| Total Liabilities And Equity | $30,243 | $27,681 | $18,922 | $15,812 | $13,958 |